1. Characterization of p53 Wild-Type and Null Isogenic Colorectal Cancer Cell Lines Resistant to 5-Fluorouracil, Oxaliplatin, and Irinotecan
   John Boyer et al, 2004, Clinical Cancer Research CrossRef
2. ERCC1 and Clinical Resistance to Platinum-Based Therapy
   Eddie Reed, 2005, Clinical Cancer Research CrossRef
3. Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers
   Ellen V. Stevens et al, 2008, Molecular Cancer Therapeutics CrossRef